COLGATE PALMOLIVE CO·4

Feb 10, 4:21 PM ET

Malcolm Gregory 4

4 · COLGATE PALMOLIVE CO · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Colgate (CL) EVP & Controller Malcolm Gregory Exercises Options, Sells Shares

What Happened

  • Malcolm Gregory, EVP and Controller of Colgate-Palmolive Co. (CL), exercised 12,747 stock options and immediately sold the same 12,747 shares on Feb 6, 2026. The options were exercised at a weighted price of $76.41 (total exercise cost reported as $973,998) and the shares were sold in the open market at a weighted average price of $94.91 for total gross sale proceeds of $1,209,822. This is a cashless exercise/sale (exercise followed by an immediate sale), which is typically a routine liquidity/compensation event rather than an overt bullish purchase.

Key Details

  • Transaction date: 2026-02-06.
  • Option exercise: 12,747 shares at $76.41 per share = $973,998 (footnote F1: options under issuer's incentive plan).
  • Sale: 12,747 shares sold at a weighted average price $94.79–$95.01 (reported weighted avg $94.91) = $1,209,822 (footnote F3 explains the price range).
  • Cashless handling: A portion of the sale proceeds was delivered to the issuer to cover the exercise price and related tax withholding (footnote F2).
  • Reported a separate derivative disposal line at $0 consistent with the conversion/exercise of the option (Form 4 reporting detail).
  • Vesting note: Options vested in one‑third increments beginning on the first anniversary of the Sept 10, 2020 grant date (footnote F4).
  • Shares owned after the transaction: not specified in the data provided in this summary; see the Form 4 for the insider’s post-transaction holdings.
  • Filing timeliness: filing date 2026-02-10 for a 2026-02-06 transaction (check the Form 4 for any tardiness notation).

Context

  • This was an exercise of previously granted options followed by an immediate sale (a common cashless exercise to cover costs and taxes). Such transactions are usually routine compensation-related actions rather than a direct signal of the insider’s view on the company’s near-term stock performance.
  • For deeper detail (exact per-trade prices, post-transaction holdings, or any 10b5-1 plan notes), retail investors should review the complete Form 4 filing (Accession 0001225208-26-001593).

Insider Transaction Report

Form 4
Period: 2026-02-06
Malcolm Gregory
EVP and Controller
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-06$76.41/sh+12,747$973,99824,626 total
  • Sale

    Common Stock

    [F2][F3]
    2026-02-06$94.91/sh12,747$1,209,82211,879 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F4]
    2026-02-0612,7470 total
    Exercise: $76.41Exp: 2028-09-10Common Stock (12,747 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,554
Footnotes (4)
  • [F1]Exercise of stock options awarded under the issuer's incentive compensation plan.
  • [F2]Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
  • [F3]Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.79 to $95.01 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact|2026-02-10

Documents

1 file
  • 4
    doc4.xmlPrimary